Juan Horcajada to Middle Aged
This is a "connection" page, showing publications Juan Horcajada has written about Middle Aged.
Connection Strength
0.114
-
Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical. J Infect. 2019 09; 79(3):253-261.
Score: 0.013
-
Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients? Molecules. 2019 Feb 01; 24(3).
Score: 0.013
-
High-dose daptomycin together with rifampin as salvage therapy for prosthetic joint infections. Med Clin (Barc). 2017 09 08; 149(5):223-224.
Score: 0.011
-
Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa. BMC Infect Dis. 2017 01 05; 17(1):11.
Score: 0.011
-
Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate. Int J Antimicrob Agents. 2016 Dec; 48(6):725-727.
Score: 0.011
-
Composition of the immunoglobulin G glycome associates with the severity of COVID-19. Glycobiology. 2021 05 03; 31(4):372-377.
Score: 0.004
-
Epigenome-wide association study of COVID-19 severity with respiratory failure. EBioMedicine. 2021 Apr; 66:103339.
Score: 0.004
-
Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection. Nutrients. 2021 Feb 09; 13(2).
Score: 0.004
-
Comorbidities and Mortality in Patients With COVID-19 Aged 60 Years and Older in a University Hospital in Spain. Arch Bronconeumol (Engl Ed). 2020 Nov; 56(11):756-758.
Score: 0.004
-
COVID-19 in Grade 4-5 Chronic Kidney Disease Patients. Kidney Blood Press Res. 2020; 45(5):768-774.
Score: 0.004
-
Comorbidities and Mortality in Patients With COVID-19 Aged 60 Years and Older in a University Hospital in Spain. Arch Bronconeumol (Engl Ed). 2020 Nov; 56(11):756-758.
Score: 0.004
-
Linezolid Dosing in Patients With Liver Cirrhosis: Standard Dosing Risk Toxicity. Ther Drug Monit. 2019 12; 41(6):732-739.
Score: 0.003
-
Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia. J Antimicrob Chemother. 2019 11 01; 74(11):3268-3273.
Score: 0.003
-
Risk of hospital readmission and associated factors after a positive sample for a multidrug-resistant microorganism. Eur J Public Health. 2019 10 01; 29(5):981-986.
Score: 0.003
-
Metabolomic Profile of ARDS by Nuclear Magnetic Resonance Spectroscopy in Patients With H1N1 Influenza Virus Pneumonia. Shock. 2018 11; 50(5):504-510.
Score: 0.003
-
Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial. JAMA. 2018 02 27; 319(8):788-799.
Score: 0.003
-
Discriminant biomarkers of acute respiratory distress syndrome associated to H1N1 influenza identified by metabolomics HPLC-QTOF-MS/MS platform. Electrophoresis. 2017 09; 38(18):2341-2348.
Score: 0.003
-
Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections. Antimicrob Agents Chemother. 2017 08; 61(8).
Score: 0.003
-
Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial. PLoS One. 2017; 12(4):e0173802.
Score: 0.003
-
C-reactive protein may misdiagnose prosthetic joint infections, particularly chronic and low-grade infections. Int Orthop. 2017 07; 41(7):1315-1319.
Score: 0.003
-
Invasive aspergillosis in kidney transplant recipients: a cohort study. Exp Clin Transplant. 2014 Apr; 12(2):101-5.
Score: 0.002
-
Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study. BMC Infect Dis. 2012 Oct 05; 12:245.
Score: 0.002